Navigating renal safety in the biologic treatment of psoriasis: from immunologic mechanisms to clinical practice

• by Zijie Tang, Jintong Wu, Meihan Dong, Chengxin Li, Rui Wang

• May 1, 2026

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

• by Andrea Surnit

• May 5, 2026

• 4 min

Biologics Tied to Lower Eye Risk in Psoriasis

Real-world data suggest lower rates of ocular surface disease with biologics vs nonbiologic systemic therapy.

• by Andrea Surnit

• April 20, 2026

• 2 min

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min